In case you missed them, here are the top 10 most widely read articles on TheStreet.com for the past seven days (as of April 27). Scott Moritz reports on Lucent and Melissa Davis looks at some well-timed stock options for Caremark execs.

1. Citigroup Cuts Dell to Sell by TSC Staff, published April 21 at 8:47 a.m. EDT.

It says the PC giant needs to consider letting margins shrink.

2. Google at $600 Isn't So Eye-Popping by Jim Cramer, published April 22 at 9:59 a.m. EDT.

It's just math, based on the company's growth rate. Remember, this is an S&P 500 company now.

3. Getting Played by Apple by Troy Wolverton, published April 25 at 10:42 a.m. EDT.

Dependence on the omnipotent iPod maker has left PortalPlayer -- and some analysts -- in the lurch.

4. Lucent Dims the Lights by Scott Moritz, published April 25 at 1:46 p.m. EDT.

The company won't provide further guidance after its latest debacle.

5. The Best of the Biotech Bums by Alan Farley, published April 24 at 2:47 p.m. EDT.

The sector is underperforming badly, but a few small- and mid-cap stocks are worth buying.

6. Limbering Up for Lucent by Scott Moritz, published April 24 at 1:32 p.m. EDT.

Investors want to know how wireless gear is looking.

7. Caremark's Uncanny Timing by Melissa Davis, published April 25 at 7:04 a.m. EDT.

Executives just happened to get a big options grant on the same day the stock set a 2005 low.

8. Travelzoo Roars Again by Jonathan Berr, published April 24 at 2:55 p.m. EDT.

The stock rises 10% and has doubled over a week.

9. Intel Unveils New PC Platform by Alexei Oreskovic, published April 24 at 4:29 p.m. EDT.

The chipmaker introduces vPro, a technology to improve the management and security of PCs.

10. Motorola Flexes Its Muscle by Scott Moritz, published April 24 at 10:47 a.m. EDT.

The Razr maker grabs cell phone market share away from Nokia.

If you liked this article you might like

Opinion: Don't Question the Almighty

Opinion: Don't Question the Almighty

What You're Missing on RealMoney

What You're Missing on RealMoney

How RealMoney Can Prevent a Disaster

How RealMoney Can Prevent a Disaster

Profit With RealMoney

Profit With RealMoney

The Bonanza Calls of Biotech Select

The Bonanza Calls of Biotech Select